Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

925 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:42 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2Active, not recruitingINTERVENTIONAL

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

ClinicalTrials.gov · NCT06948825 · Registry updated: 2026-11-06

Condition / research focus: Weight Loss; Gestational Diabetes Mellitus in Pregnancy; Postpartum Care
Sponsor: George Washington University
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-27. Completion: 2027-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin Hcl 850Mg Tab (drug)
Lifestyle Intervention (behavioral)
Enhanced Lifestyle Intervention (behavioral)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Milken Institute School of Public Health - The George Washington University
Washington D.C., District of Columbia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

ClinicalTrials.gov · NCT04063501 · Registry updated: 2026-11-03

Condition / research focus: Lung Cancer
Sponsor: NYU Langone Health
Countries with listed sites: United States
Registry dates and results: Start: 2021-02-09. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bronchoscopy (other)
Research Procedures (other)

Where the study takes place — 1 listed sites

NYU Langone Health
New York, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

ClinicalTrials.gov · NCT07340827 · Registry updated: 2026-10-29

Condition / research focus: Infertility
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2026-02-05. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin alfa/lutropin alfa (MBJ-0011) (combination_product) — also listed as: MBJ-0011, r-hFSH/r-hLH
hMG (drug)
Cetrorelix acetate (drug) — also listed as: GnRH, antagonist
Coriogonadotropin alfa (drug) — also listed as: r-hCG
Progesterone gel (drug)

Where the study takes place — 21 listed sites

Akita University Hospital - Dept of Obstetrics/Gynecology
Akita, Akita, Japan
Site recruitment: Recruiting
Kameda IVF Clinic Makuhari - Dept of Obstetrics/Gynecology
Chiba, Chiba, Japan
Site recruitment: Recruiting
YOKOTA Maternity Hospital - Dept of Reproductive Medical Gynecology
Maebashi, Gunma, Japan
Site recruitment: Recruiting
Kamiya Ladies Clinic - Dept of Gynecology
Sapporo, Hokkaido, Japan
Site recruitment: Recruiting
Hanabusa Women's Clinic Hanabusa Women's Central Fertility Clinic - Dept of Obstetrics/Gynecology
Kobe, Hyōgo, Japan
Site recruitment: Recruiting
Sophia Ladies Clinic - Dept of Obstetrics/Gynecology
Sagamihara-shi, Kanagawa, Japan
Site recruitment: Recruiting
Ladies Clinic Cosmos - Dept of Infertility Treatment
Kochi, Kochi, Japan
Site recruitment: Recruiting
Nagano Municipal Hospital - Dept of Gynecology
Nagano, Nagano, Japan
Site recruitment: Recruiting
JA-Nagano Shinonoi General Hospital - Dept of Obstetrics/Gynecology
Nagano, Nagano, Japan
Site recruitment: Recruiting
Sora no Mori Clinic - Dept of Obstetrics/Gynecology
Shimajiri-gun, Okinawa, Japan
Site recruitment: Recruiting
Sankeikai IVF Osaka Clinic - Dept of Obstetrics/Gynecology
Higashiosaka-shi, Osaka, Japan
Site recruitment: Recruiting
Haruki Ladies Clinic - Dept of Gynecology
Osaka, Osaka, Japan
Site recruitment: Recruiting
KASHIWAZAKI OB/GYN CLINIC - Dept of Obstetrics/Gynecology
Saitama-shi, Saitama, Japan
Site recruitment: Recruiting
Omiya Ladies Clinic - Dept of Gynecology
Saitama-shi, Saitama, Japan
Site recruitment: Recruiting
Dokkyo Medical University Hospital - Dept of Reproduction Center
Shimotsuga-gun, Tochigi, Japan
Site recruitment: Recruiting
Tokushima University Hospital - Dept of Obstetrics/Gynecology
Tokushima, Tokushima, Japan
Site recruitment: Recruiting
Juntendo University Hospital - Dept of Obstetrics/ Gynecology
Bunkyō City, Tokyo-To, Japan
Site recruitment: Recruiting
University of Tokyo Hospital - Dept of Obstetrics
Bunkyō City, Tokyo-To, Japan
Site recruitment: Recruiting
Sugiyama Clinic Marunouchi - Dept of Obstetrics/ Gynecology
Chiyoda-ku, Tokyo-To, Japan
Site recruitment: Recruiting
Toho University Omori Medical Center - Dept of Obstetrics/Gynecology
Ōta-ku, Tokyo-To, Japan
Site recruitment: Recruiting
Sugiyama Clinic Shinjuku - Dept of Reproductive Medical
Shinjuku-ku, Tokyo-To, Japan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood

ClinicalTrials.gov · NCT07493720 · Registry updated: 2026-10-27

Condition / research focus: Pregnancy
Sponsor: University of Nebraska
Countries with listed sites: United States
Registry dates and results: Start: 2026-09. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Beta-hCG (diagnostic_test)

Where the study takes place — 1 listed sites

University of Nebraska Medical Center
Omaha, Nebraska, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Predicate and Lay User-HCP Comparison Study of a Multi-Level Urine hCG Pregnancy Test

ClinicalTrials.gov · NCT06516211 · Registry updated: 2026-10-26

Condition / research focus: Pregnancy
Sponsor: Conceptra Biosciences, LLC
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-30. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clara Pregnancy Test (device)
Professional Marketed Pregnancy Test (device)

Where the study takes place — 1 listed sites

FPA Women's Health
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Using Exercise-testing to Explore Patient Differences in Severe Asthma

ClinicalTrials.gov · NCT05733143 · Registry updated: 2026-10-26

Condition / research focus: Asthma
Sponsor: Queen's University, Belfast
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2023-07-18. Completion: 2025-01-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cardiopulmonary exercise stress test (CPEST) (other)

Where the study takes place — 1 listed sites

Queen's University Belfast
Belfast, Northern Ireland, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

ClinicalTrials.gov · NCT07891793 · Registry updated: 2026-10-23

Condition / research focus: Infertile Patient Undergoing ICSI Procedure
Sponsor: Assisting Nature
Countries with listed sites: Greece
Registry dates and results: Start: 2024-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa 150 μg (drug) — also listed as: Elonva 150μg
GnRH antagonist (drug)
Progesterone (drug)
Human Menopausal Gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Assisting Nature Fertility Clinic
Thessaloniki, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury

ClinicalTrials.gov · NCT06518174 · Registry updated: 2026-10-22

Condition / research focus: Uterine Injury
Sponsor: University of Colorado, Denver
Countries with listed sites: United States
Registry dates and results: Start: 2025-02-25. Completion: 2026-06-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MRI, SWE, and US evaluation (diagnostic_test)

Where the study takes place — 1 listed sites

University of Colorado
Aurora, Colorado, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Verapamil In Preclinical Type 1 Diabetes

ClinicalTrials.gov · NCT07880769 · Registry updated: 2026-10-22

Condition / research focus: Type 1 Diabetes
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2027-01. Completion: 2031-03 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release (drug)
Placebo (other)
blood sampling (biological)
EKG and cardiological evaluation (other)
Continuous Glucose Monitoring (CGM) (other)
Urine collection (other)

Where the study takes place — 1 listed sites

Hôpital Robert Debré
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

LE + CC vs. LE for Ovulation Induction

ClinicalTrials.gov · NCT06934785 · Registry updated: 2026-10-20

Condition / research focus: Letrozole; Clomiphene Citrate; Ovulation Disorder; Ovulation Induction
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2025-04-28. Completion: 2027-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IUI or intercourse (procedure)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

hCG Treatment for Rehabilitation From a TBI

ClinicalTrials.gov · NCT07557615 · Registry updated: 2026-10-19

Condition / research focus: Traumatic Brain Injury
Sponsor: VA Office of Research and Development
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug) — also listed as: Choriogonadotropin alfa
Placebo (other)

Where the study takes place — 1 listed sites

William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Clomiphene Citrate Alone Versus Clomiphene Plus Metformin as First Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT07872501 · Registry updated: 2026-10-13

Condition / research focus: Polycystic Ovary Syndrome (PCOS), Anovulatory Infertility
Sponsor: Independent University Hospital, Pakistan
Countries with listed sites: Pakistan
Registry dates and results: Start: 2025-01-01. Completion: 2025-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphane citrate + Metformin (drug)
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

Independent University Hospital
Faisalābad, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

ClinicalTrials.gov · NCT07372859 · Registry updated: 2026-10-09

Condition / research focus: Healthy Volunteer
Sponsor: French Cardiology Society
Countries with listed sites: France
Registry dates and results: Start: 2027-03-20. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Echocardiography (procedure)
Arterial ultrasound (procedure)
Blood sampling (biological)
Scales and questionnaire (behavioral)
Vital signs (procedure)
Urinary test (biological)

Where the study takes place — 1 listed sites

Hôpital Henri Mondor, APHP
Créteil, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

ClinicalTrials.gov · NCT04541212 · Registry updated: 2026-10-08

Condition / research focus: Breast Cancer; Lymphoma; Leukemia
Sponsor: Montreal Heart Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2021-12-02. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cardiac Imaging (diagnostic_test) — also listed as: Blood tests
Data Collection (other)

Where the study takes place — 6 listed sites

Centre Hospitalier de l'université de Montréal (CHUM)
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
Montreal Heart Institute
Montreal, Quebec, Canada
Site recruitment: Not reported
CISSSS de Lanaudière_Hôpital Pierre LeGardeur (referring site)
Terrebonne, Quebec (QC), Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients

ClinicalTrials.gov · NCT06003400 · Registry updated: 2026-10-08

Condition / research focus: Diabetic Foot Ulcer
Sponsor: Tri.O Medical LTD
Countries with listed sites: Israel
Registry dates and results: Start: 2023-03-29. Completion: 2025-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Study treatment administration (TriO FITT) (device)
Physical Examination (diagnostic_test)
Vital Signs (diagnostic_test)
Hematology Blood Tests (diagnostic_test)
Biochemistry Blood Test (diagnostic_test)
Wound Digital Photography (diagnostic_test)
Urine pregnancy test (diagnostic_test)
Visual Analogue Scale (other)
SF-36 (other)
Wounds evaluation (diagnostic_test)

Where the study takes place — 1 listed sites

Hilel Yafe Medical Center
Hadera, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive Treatments

ClinicalTrials.gov · NCT07855783 · Registry updated: 2026-10-07

Condition / research focus: IVF Outcomes; Prediction Models; Infertility Assisted Reproductive Technology; Live Birth
Sponsor: BetaPlus Center for Reproductive Medicine
Countries with listed sites: Croatia
Registry dates and results: Start: 2026-01-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Machine-Learning Model for Prediction of Pregnancy Outcomes (other)

Where the study takes place — 2 listed sites

Clinical Hospital Center
Rijeka, Croatia
Site recruitment: Recruiting
BetaPlus Center for Reproductive Medicine
Zagreb, Croatia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

ClinicalTrials.gov · NCT07861399 · Registry updated: 2026-10-06

Condition / research focus: ICSI; IVF; Normal Responders; Infertility Assisted Reproductive Technology; Infertile Women Undergoing IVF or ICSI; Infertile Women Undergoing ART; Triggering Ovulation; Oocyte Maturation
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-09-01. Completion: 2028-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: Triptorelin acetate and human chorionic gonadotropin
hCG trigger (drug) — also listed as: human chorionic gonadotropin

Where the study takes place — 1 listed sites

ART Unit, International Islamic Center for Population Studies and Research, Al-Azhar University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

ClinicalTrials.gov · NCT07425990 · Registry updated: 2026-09-29

Condition / research focus: Infertility Female; Frozen Embryo Transfer (FET)
Sponsor: University of Novi Sad
Countries with listed sites: Serbia
Registry dates and results: Start: 2026-03-13. Completion: 2027-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (Aromatase Inhibitors) (drug)
Choriogonadotropin alpha (r-hCG) (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Specialized Gynecological Hospital "Ferona" Novi Sad
Novi Sad, Serbia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Active, not recruitingINTERVENTIONAL

Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.

ClinicalTrials.gov · NCT07842796 · Registry updated: 2026-09-25

Condition / research focus: Ectopic Pregnancy
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-12-15. Completion: 2026-12-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug)
Methotrexate (drug)

Where the study takes place — 1 listed sites

Benha university
Banhā, El Qalyoubia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

hCG Priming in Women With Diminished Ovarian Reserve

ClinicalTrials.gov · NCT07108621 · Registry updated: 2026-09-21

Condition / research focus: Infertility, Female; Ovarian Reserve; In Vitro Fertilization (IVF)
Sponsor: Kristine Loessl
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-01-25. Completion: 2031-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriongonadotropin alfa (hCG) (drug)
Isotonic NaCl (Placebo) (drug)

Where the study takes place — 1 listed sites

Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hosital Rigshospitalet
Copenhagen, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

925 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:42 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2Active, not recruitingINTERVENTIONAL

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

ClinicalTrials.gov · NCT06948825 · Registry updated: 2026-11-06

Condition / research focus: Weight Loss; Gestational Diabetes Mellitus in Pregnancy; Postpartum Care
Sponsor: George Washington University
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-27. Completion: 2027-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin Hcl 850Mg Tab (drug)
Lifestyle Intervention (behavioral)
Enhanced Lifestyle Intervention (behavioral)

Where the study takes place — 1 listed sites

Milken Institute School of Public Health - The George Washington University
Washington D.C., District of Columbia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

ClinicalTrials.gov · NCT04063501 · Registry updated: 2026-11-03

Condition / research focus: Lung Cancer
Sponsor: NYU Langone Health
Countries with listed sites: United States
Registry dates and results: Start: 2021-02-09. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bronchoscopy (other)
Research Procedures (other)

Where the study takes place — 1 listed sites

NYU Langone Health
New York, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

ClinicalTrials.gov · NCT07340827 · Registry updated: 2026-10-29

Condition / research focus: Infertility
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2026-02-05. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin alfa/lutropin alfa (MBJ-0011) (combination_product) — also listed as: MBJ-0011, r-hFSH/r-hLH
hMG (drug)
Cetrorelix acetate (drug) — also listed as: GnRH, antagonist
Coriogonadotropin alfa (drug) — also listed as: r-hCG
Progesterone gel (drug)

Where the study takes place — 21 listed sites

Akita University Hospital - Dept of Obstetrics/Gynecology
Akita, Akita, Japan
Site recruitment: Recruiting
Kameda IVF Clinic Makuhari - Dept of Obstetrics/Gynecology
Chiba, Chiba, Japan
Site recruitment: Recruiting
YOKOTA Maternity Hospital - Dept of Reproductive Medical Gynecology
Maebashi, Gunma, Japan
Site recruitment: Recruiting
Kamiya Ladies Clinic - Dept of Gynecology
Sapporo, Hokkaido, Japan
Site recruitment: Recruiting
Hanabusa Women's Clinic Hanabusa Women's Central Fertility Clinic - Dept of Obstetrics/Gynecology
Kobe, Hyōgo, Japan
Site recruitment: Recruiting
Sophia Ladies Clinic - Dept of Obstetrics/Gynecology
Sagamihara-shi, Kanagawa, Japan
Site recruitment: Recruiting
Ladies Clinic Cosmos - Dept of Infertility Treatment
Kochi, Kochi, Japan
Site recruitment: Recruiting
Nagano Municipal Hospital - Dept of Gynecology
Nagano, Nagano, Japan
Site recruitment: Recruiting
JA-Nagano Shinonoi General Hospital - Dept of Obstetrics/Gynecology
Nagano, Nagano, Japan
Site recruitment: Recruiting
Sora no Mori Clinic - Dept of Obstetrics/Gynecology
Shimajiri-gun, Okinawa, Japan
Site recruitment: Recruiting
Sankeikai IVF Osaka Clinic - Dept of Obstetrics/Gynecology
Higashiosaka-shi, Osaka, Japan
Site recruitment: Recruiting
Haruki Ladies Clinic - Dept of Gynecology
Osaka, Osaka, Japan
Site recruitment: Recruiting
KASHIWAZAKI OB/GYN CLINIC - Dept of Obstetrics/Gynecology
Saitama-shi, Saitama, Japan
Site recruitment: Recruiting
Omiya Ladies Clinic - Dept of Gynecology
Saitama-shi, Saitama, Japan
Site recruitment: Recruiting
Dokkyo Medical University Hospital - Dept of Reproduction Center
Shimotsuga-gun, Tochigi, Japan
Site recruitment: Recruiting
Tokushima University Hospital - Dept of Obstetrics/Gynecology
Tokushima, Tokushima, Japan
Site recruitment: Recruiting
Juntendo University Hospital - Dept of Obstetrics/ Gynecology
Bunkyō City, Tokyo-To, Japan
Site recruitment: Recruiting
University of Tokyo Hospital - Dept of Obstetrics
Bunkyō City, Tokyo-To, Japan
Site recruitment: Recruiting
Sugiyama Clinic Marunouchi - Dept of Obstetrics/ Gynecology
Chiyoda-ku, Tokyo-To, Japan
Site recruitment: Recruiting
Toho University Omori Medical Center - Dept of Obstetrics/Gynecology
Ōta-ku, Tokyo-To, Japan
Site recruitment: Recruiting
Sugiyama Clinic Shinjuku - Dept of Reproductive Medical
Shinjuku-ku, Tokyo-To, Japan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood

ClinicalTrials.gov · NCT07493720 · Registry updated: 2026-10-27

Condition / research focus: Pregnancy
Sponsor: University of Nebraska
Countries with listed sites: United States
Registry dates and results: Start: 2026-09. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Beta-hCG (diagnostic_test)

Where the study takes place — 1 listed sites

University of Nebraska Medical Center
Omaha, Nebraska, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Predicate and Lay User-HCP Comparison Study of a Multi-Level Urine hCG Pregnancy Test

ClinicalTrials.gov · NCT06516211 · Registry updated: 2026-10-26

Condition / research focus: Pregnancy
Sponsor: Conceptra Biosciences, LLC
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-30. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clara Pregnancy Test (device)
Professional Marketed Pregnancy Test (device)

Where the study takes place — 1 listed sites

FPA Women's Health
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Using Exercise-testing to Explore Patient Differences in Severe Asthma

ClinicalTrials.gov · NCT05733143 · Registry updated: 2026-10-26

Condition / research focus: Asthma
Sponsor: Queen's University, Belfast
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2023-07-18. Completion: 2025-01-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cardiopulmonary exercise stress test (CPEST) (other)

Where the study takes place — 1 listed sites

Queen's University Belfast
Belfast, Northern Ireland, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

ClinicalTrials.gov · NCT07891793 · Registry updated: 2026-10-23

Condition / research focus: Infertile Patient Undergoing ICSI Procedure
Sponsor: Assisting Nature
Countries with listed sites: Greece
Registry dates and results: Start: 2024-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa 150 μg (drug) — also listed as: Elonva 150μg
GnRH antagonist (drug)
Progesterone (drug)
Human Menopausal Gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Assisting Nature Fertility Clinic
Thessaloniki, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury

ClinicalTrials.gov · NCT06518174 · Registry updated: 2026-10-22

Condition / research focus: Uterine Injury
Sponsor: University of Colorado, Denver
Countries with listed sites: United States
Registry dates and results: Start: 2025-02-25. Completion: 2026-06-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MRI, SWE, and US evaluation (diagnostic_test)

Where the study takes place — 1 listed sites

University of Colorado
Aurora, Colorado, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Verapamil In Preclinical Type 1 Diabetes

ClinicalTrials.gov · NCT07880769 · Registry updated: 2026-10-22

Condition / research focus: Type 1 Diabetes
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2027-01. Completion: 2031-03 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release (drug)
Placebo (other)
blood sampling (biological)
EKG and cardiological evaluation (other)
Continuous Glucose Monitoring (CGM) (other)
Urine collection (other)

Where the study takes place — 1 listed sites

Hôpital Robert Debré
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

LE + CC vs. LE for Ovulation Induction

ClinicalTrials.gov · NCT06934785 · Registry updated: 2026-10-20

Condition / research focus: Letrozole; Clomiphene Citrate; Ovulation Disorder; Ovulation Induction
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2025-04-28. Completion: 2027-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IUI or intercourse (procedure)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

hCG Treatment for Rehabilitation From a TBI

ClinicalTrials.gov · NCT07557615 · Registry updated: 2026-10-19

Condition / research focus: Traumatic Brain Injury
Sponsor: VA Office of Research and Development
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug) — also listed as: Choriogonadotropin alfa
Placebo (other)

Where the study takes place — 1 listed sites

William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Clomiphene Citrate Alone Versus Clomiphene Plus Metformin as First Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT07872501 · Registry updated: 2026-10-13

Condition / research focus: Polycystic Ovary Syndrome (PCOS), Anovulatory Infertility
Sponsor: Independent University Hospital, Pakistan
Countries with listed sites: Pakistan
Registry dates and results: Start: 2025-01-01. Completion: 2025-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphane citrate + Metformin (drug)
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

Independent University Hospital
Faisalābad, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

ClinicalTrials.gov · NCT07372859 · Registry updated: 2026-10-09

Condition / research focus: Healthy Volunteer
Sponsor: French Cardiology Society
Countries with listed sites: France
Registry dates and results: Start: 2027-03-20. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Echocardiography (procedure)
Arterial ultrasound (procedure)
Blood sampling (biological)
Scales and questionnaire (behavioral)
Vital signs (procedure)
Urinary test (biological)

Where the study takes place — 1 listed sites

Hôpital Henri Mondor, APHP
Créteil, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

ClinicalTrials.gov · NCT04541212 · Registry updated: 2026-10-08

Condition / research focus: Breast Cancer; Lymphoma; Leukemia
Sponsor: Montreal Heart Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2021-12-02. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cardiac Imaging (diagnostic_test) — also listed as: Blood tests
Data Collection (other)

Where the study takes place — 6 listed sites

Centre Hospitalier de l'université de Montréal (CHUM)
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Site recruitment: Not reported
CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
Montreal Heart Institute
Montreal, Quebec, Canada
Site recruitment: Not reported
CISSSS de Lanaudière_Hôpital Pierre LeGardeur (referring site)
Terrebonne, Quebec (QC), Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients

ClinicalTrials.gov · NCT06003400 · Registry updated: 2026-10-08

Condition / research focus: Diabetic Foot Ulcer
Sponsor: Tri.O Medical LTD
Countries with listed sites: Israel
Registry dates and results: Start: 2023-03-29. Completion: 2025-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Study treatment administration (TriO FITT) (device)
Physical Examination (diagnostic_test)
Vital Signs (diagnostic_test)
Hematology Blood Tests (diagnostic_test)
Biochemistry Blood Test (diagnostic_test)
Wound Digital Photography (diagnostic_test)
Urine pregnancy test (diagnostic_test)
Visual Analogue Scale (other)
SF-36 (other)
Wounds evaluation (diagnostic_test)

Where the study takes place — 1 listed sites

Hilel Yafe Medical Center
Hadera, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive Treatments

ClinicalTrials.gov · NCT07855783 · Registry updated: 2026-10-07

Condition / research focus: IVF Outcomes; Prediction Models; Infertility Assisted Reproductive Technology; Live Birth
Sponsor: BetaPlus Center for Reproductive Medicine
Countries with listed sites: Croatia
Registry dates and results: Start: 2026-01-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Machine-Learning Model for Prediction of Pregnancy Outcomes (other)

Where the study takes place — 2 listed sites

Clinical Hospital Center
Rijeka, Croatia
Site recruitment: Recruiting
BetaPlus Center for Reproductive Medicine
Zagreb, Croatia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

ClinicalTrials.gov · NCT07861399 · Registry updated: 2026-10-06

Condition / research focus: ICSI; IVF; Normal Responders; Infertility Assisted Reproductive Technology; Infertile Women Undergoing IVF or ICSI; Infertile Women Undergoing ART; Triggering Ovulation; Oocyte Maturation
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-09-01. Completion: 2028-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: Triptorelin acetate and human chorionic gonadotropin
hCG trigger (drug) — also listed as: human chorionic gonadotropin

Where the study takes place — 1 listed sites

ART Unit, International Islamic Center for Population Studies and Research, Al-Azhar University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

ClinicalTrials.gov · NCT07425990 · Registry updated: 2026-09-29

Condition / research focus: Infertility Female; Frozen Embryo Transfer (FET)
Sponsor: University of Novi Sad
Countries with listed sites: Serbia
Registry dates and results: Start: 2026-03-13. Completion: 2027-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (Aromatase Inhibitors) (drug)
Choriogonadotropin alpha (r-hCG) (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Specialized Gynecological Hospital "Ferona" Novi Sad
Novi Sad, Serbia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Active, not recruitingINTERVENTIONAL

Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.

ClinicalTrials.gov · NCT07842796 · Registry updated: 2026-09-25

Condition / research focus: Ectopic Pregnancy
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-12-15. Completion: 2026-12-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug)
Methotrexate (drug)

Where the study takes place — 1 listed sites

Benha university
Banhā, El Qalyoubia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

hCG Priming in Women With Diminished Ovarian Reserve

ClinicalTrials.gov · NCT07108621 · Registry updated: 2026-09-21

Condition / research focus: Infertility, Female; Ovarian Reserve; In Vitro Fertilization (IVF)
Sponsor: Kristine Loessl
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-01-25. Completion: 2031-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriongonadotropin alfa (hCG) (drug)
Isotonic NaCl (Placebo) (drug)

Where the study takes place — 1 listed sites

Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hosital Rigshospitalet
Copenhagen, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →